Ligand validation:7HLK

EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7HLK_EPE_B_202	13%	59%	0.195	0.729	0.6	0.96	1	-	3	0	100%	1
7HLA_EPE_B_203	46%	63%	0.148	0.882	0.44	0.95	-	2	1	0	100%	0.54
7HMP_EPE_B_204	28%	53%	0.179	0.828	0.72	1.08	1	1	2	0	100%	0.58
7HLJ_EPE_B_203	21%	70%	0.198	0.804	0.43	0.73	-	1	1	0	100%	0.39
7HNJ_EPE_B_204	17%	62%	0.178	0.755	0.66	0.8	1	1	1	0	100%	1
7HNI_EPE_B_203	13%	45%	0.193	0.727	0.73	1.36	1	2	2	0	100%	1
1XX1_EPE_C_2003	100%	37%	0.024	0.996	0.73	1.72	1	4	1	0	100%	1
3EC7_EPE_E_401	100%	10%	0.031	0.993	1.1	3.18	1	11	1	0	100%	1
2BDU_EPE_B_402	100%	29%	0.033	0.993	0.87	1.95	1	5	0	0	100%	1
3R7A_EPE_B_301	99%	39%	0.053	0.987	0.79	1.56	1	4	1	0	100%	1
4WX4_EPE_A_302	99%	53%	0.064	0.994	0.99	0.82	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.